tiprankstipranks
Australian Clinical Labs Reports Change in Substantial Shareholder Interests
Company Announcements

Australian Clinical Labs Reports Change in Substantial Shareholder Interests

Story Highlights

Maximize Your Portfolio with Data Driven Insights:

  • Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
  • Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio

Australian Clinical Labs Ltd ( (AU:ACL) ) has issued an update.

Australian Clinical Labs Limited recently reported a change in the interests of a substantial holder, Australian Ethical Investment Limited, which has decreased its voting power from 7.30% to 6.26%. This change highlights a significant shift in shareholder dynamics, potentially impacting the company’s governance and strategic direction. Such a decrease in voting power could influence the company’s decision-making processes and affect its positioning within the industry.

More about Australian Clinical Labs Ltd

YTD Price Performance: 6.10%

Average Trading Volume: 581,305

Technical Sentiment Consensus Rating: Sell

Current Market Cap: A$720.1M

See more insights into ACL stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App